1. Pre-treatment Neutrophil-to-Lymphocyte Ratio significantly affects progression free survival in positive EGFR mutation advanced lung adenocarcinoma with EGFR-TKI treatment in Bali, Indonesia
   Ni Putu Ayu Widiasari et al, 2023, Romanian Journal of Internal Medicine CrossRef
2. Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion
   Hiroshi Nokihara et al, 2022, BMC Cancer CrossRef
3. Prognostic impact of pleural effusion in patients with malignancy: A systematic review and meta‐analysis
   Yuan Yang et al, 2022, Clinical and Translational Science CrossRef
4. The Prognostic Value of Baseline Distant Metastasis in Icotinib-Treated Patients with EGFR-Mutated Stage IV Non-Small Cell Lung Cancer
   Long Wang et al, 2021, Cancer Management and Research CrossRef
5. Top advances of the year: Targeted therapy for lung cancer
   Maisam Makarem et al, 2024, Cancer CrossRef
6. Prognostic value of venous thromboembolism in patients with advanced pancreatic cancer: a systematic review and meta-analysis
   Kaifeng Su et al, 2024, Frontiers in Oncology CrossRef
7. Risk factors for rib metastases of lung cancer patients with high-uptake rib foci on 99Tcm-MDP SPECT/CT
   Yuanyuan YANG et al, 2024, The Quarterly Journal of Nuclear Medicine and Molecular Imaging CrossRef
8. Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence
   Luyao Ao et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef